Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Ordinary Shares, nominal value EUR0.04 per share
-
Shares outstanding
-
106,324,269
-
Total 13F shares
-
23,591,614
-
Share change
-
-240,724
-
Total reported value
-
$214,685,000
-
Price per share
-
$9.10
-
Number of holders
-
51
-
Value change
-
-$8,496,818
-
Number of buys
-
23
-
Number of sells
-
22
Institutional Holders of ProQR Therapeutics N.V. - Ordinary Shares, nominal value EUR0.04 per share (PRQR) as of Q2 2019
As of 30 Jun 2019,
ProQR Therapeutics N.V. - Ordinary Shares, nominal value EUR0.04 per share (PRQR) was held by
51 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,591,614 shares.
The largest 10 holders included
ADAGE CAPITAL PARTNERS GP, L.L.C., RTW INVESTMENTS, LP, GOLDMAN SACHS GROUP INC, JENNISON ASSOCIATES LLC, ORBIMED ADVISORS LLC, Artal Group S.A., BlackRock Inc., FMR LLC, Aquilo Capital Management, LLC, and HSBC HOLDINGS PLC.
This page lists
51
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.